argus

Biocon Ltd.

NSE: BIOCONINE376G0101365,391 Cr

Timeline

Time (IST)TypeMEventSrc
19 Sept, 08:43 pmBiocon Ltd - 532523 - Buyback Of Commercial Paperbse
18 Sept, 04:24 pmBiocon Limited has informed the Exchange regarding a press release dated September 18, 2025, titled "Biocon Biologics Yesafili® (aflibercept) Now Publicly Funded in Ontario, Canada for the Advanced Treatment of Patients with Retinal Diseases".nse
17 Sept, 07:06 pmBiocon Limited has informed the Exchange about Intimation of record date for buy back of listed Commercial Paper issued by the Companynse
17 Sept, 04:16 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
17 Sept, 04:14 pmBiocon Limited has informed the Exchange regarding a press release dated September 17, 2025, titled "Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya and Aukelso , Denosumab Biosimilars".nse
13 Sept, 06:21 pmBiocon Limited has informed the Exchange about Letters to shareholders under 100 Days Campaign Saksham Niveshaknse
12 Sept, 05:34 pmBiocon Limited has informed the Exchange regarding a press release dated September 12, 2025, titled "Biocon Foundation Supports Government High School, Kicks off Construction of a New Building for 250 Students Dr C. N. Manjunath, M.P. Bengaluru Rural Constituency Performs the Groundbreaking Ceremony".nse
12 Sept, 05:32 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
12 Sept, 05:30 pmBiocon Limited has informed the Exchange regarding a press release dated September 12, 2025, titled "Biocon Foundation Supports Government High School, Kicks off Construction of a New Building for 250 Students Dr C. N. Manjunath, M.P. Bengaluru Rural Constituency Performs the Groundbreaking Ceremony ".nse
11 Sept, 12:31 amBiocon Limited has informed the Exchange regarding a press release dated September 10, 2025, titled "Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey".nse
11 Sept, 12:26 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
10 Sept, 08:11 pmBiocon Limited has informed the Exchange about Email communication to shareholders under 100 Days Campaign Saksham Niveshaknse
09 Sept, 08:12 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
09 Sept, 08:10 pmBiocon Limited has informed the Exchange about Change in Company Secretary/Compliance Officernse
09 Sept, 08:08 pmBiocon Limited has informed the Exchange regarding Outcome of Board Meeting held on September 09, 2025.nse
04 Sept, 07:21 pmBiocon Limited has informed the Exchange about Company Statementnse